Federal Circuit Will Not Reconsider Arthrex Appointment Clause Ruling
“Instead of a limited review of weak patents that Director Kappos assured me would amount to no more than 500 cases a year, the AIA has created a tsunami of new cases…. The current judicial squabble over Arthrex and its implications may at least have the virtue of prompting Congressional review on the impact of …
Federal Circuit Will Not Reconsider Arthrex Appointment Clause Ruling Read More »